- 客服:
- 电话: 13061953619
- 微信:
AGN 210676 (Simenepag) 是一种选择性前列腺素 EP2 激动剂,从专利 US20070203222A1 化合物实施例 23 中提取,具有 5 nM 的 EC50。
AGN 210676 is a selective prostaglandin EP2 agonist extracted from patent US20070203222A1, Compound example 23, has an EC50 of 5 nM.
AGN 210676 (Compound 23) also is a less potent agonist for recombinant human prostaglandin receptors hEP3A and hDP with EC50s of 153 nM and 7749 nM, respectively. AGN 210676 is useful for the treatment of glaucoma, ocular hypertension, inflammatory bowel disease, and the other diseases or conditions disclosed herein[1].
[1]. Old, David W, et al. SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS. US20070203222A1.
动态评分
0.0